Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

CereSpir signs letter of intent to acquire rights to Chiesi's CHF-5074

July 30, 2013

Novel sleep deprivation-induced animal model for Alzheimer's disease described

July 30, 2013

Neuren reports data for NNZ-2591 from fragile X model

July 30, 2013

uniQure begins phase I trial of gene therapy for Parkinson's disease

July 30, 2013

Eisai receives positive CHMP opinion for Zonegran in pediatric patients

July 30, 2013

A novel CNTF-derived peptide restores cognitive impairment in vivo

July 30, 2013

Captisol-enabled topiramate injection receives FDA orphan drug status

July 29, 2013

Phosphagenics reaches milestone in development program for TPM/oxycodone patch

July 29, 2013

Memory improvements seen with insulin detemir in Alzheimer's disease, mild cognitive impairment

July 29, 2013

Effects of AZD-5213 on sleep evaluated in patients with MCI and Alzheimer's disease

July 29, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...